Search This Blog

Wednesday, November 30, 2022

Lilly's COVID drug bebtelovimab not currently authorized in U.S., says FDA

 

The U.S. Food and Drug Administration said on Wednesday Eli Lilly and Co's COVID-19 drug bebtelovimab is not currently authorized for emergency use in the country as it is not expected to neutralize the dominant BQ.1 and BQ.1.1 subvariants of Omicron.


No comments:

Post a Comment

Note: Only a member of this blog may post a comment.